Cellectricon to Introduce HT Transfection Platform Based on Single-Cell Technology | GenomeWeb

Swedish biotechnology company Cellectricon is working on a high-throughput instrument to transfect cells via electroporation, as well as to assay them, Inside Bioassays has learned.

The instrument, called Cellaxess, is scheduled to be launched in the first half of 2005, according to Owe Orwar, Cellectricon’s CSO and a company co-founder. Orwar also said that Cellectricon is about to begin beta-testing the instrument at two large, undisclosed pharmaceutical companies in Europe.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.